Susan Hasty, Publisher
Table of Contents . . . April 24th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis & HIV - Hepatitis C virus physiological associations defined in HIV-HCV-coinfected patients
Hepatitis C Virus - Hepatitis C virus replicon-expressed NS5A can be tagged
Hepatitis C Virus - Human ribosomal protein L18a interacts with HCV internal ribosome entry site
Hepatitis C Virus - Potent hepatitis C virus protease inhibitors are derived from macrocycles
Hepatitis E Virus - Hepatitis E virus genome analyzed from fulminant or acute self-limited hepatitis
Acute Hepatitis - In acute hepatitis, glycoprotein oligosaccharides are modified by reactive oxygen species
Apoptosis - Researchers' findings advance apoptosis research
Chronic Hepatitis - HBeAg-positive chronic hepatitis B is more responsive to entecavir than to lamivudine
Cirrhosis - Endotoxic liver damage in cirrhotic rats reduced by bosentan ET-1 blockade
Coronavirus - Coronavirus clearance is delayed via inhibition of interferon signaling in oligodendroglia
DNA Vaccine - DNA vaccination elicits anti-HBV immune responses in rhesus macaques
Genetics & Genomics - Hepatitis C virus genome sequences represent subtypes 6k and 6n and an unassigned subtype
Hepatitis B Therapy - PowderMed's Therapeutic DNA vaccine for chronic hepatitis B enters phase I trials in patients
Hepatitis B Vaccine - Chronic HBV vaccines devised based on mycobacterial heat shock protein 70
Hepatitis B Virus - Anti-hepatitis B virus activity and cross-resistance profile characterized
Hepatitis B Virus - HBeAg-negative chronic hepatitis B lamivudine monotherapy outcome predicted
Hepatitis B Virus - Hepatitis B virus may be effectively treated using telbivudine
Hepatitis B Virus - Recent findings in hepatitis B virus provide new insights
Hepatitis B Virus - Recombinant GB virus B hepatitis virus with a p7 protein developed
Hepatitis B Virus - Research in hepatitis B virus provides new insights
Hepatitis C Therapy - Idenix provides update on clinical development of valopicitabine (NM283) for hepatitis C
Hepatitis C Therapy - Schering-Plough and PTC Therapeutics collaborate to develop preclinical hepatitis C compounds
Hepatitis C Virus - Findings advance knowledge in hepatitis C virus research
Hepatitis C Virus - HCV NS3-4A Ser protease is inhibited by orally bioavailable compound
Hepatitis C Virus - HCV protease inhibitor suppresses polyprotein maturation and enhances interferon activity
Hepatitis C Virus - HCV-specific immune responses are associated with antiviral therapy nonresponse
Hepatitis C Virus - Hepatitis C virus RNA negativity occurs among HCV-seropositive blood donors
Hepatitis C Virus - Hepatitis C virus genotype 3 is associated with histopathologic liver disease
Hepatitis C Virus - Hepatitis C virus liver fibrosis predicted in patients coinfected with HIV
Hepatitis C Virus - Hepatitis C virus recurrence and graft fibrosis is treatable following liver transplantation
Hepatitis C Virus - Researchers describe findings in hepatitis C virus studies
Hepatitis C Virus - Researchers detail new studies and findings in the area of hepatitis C virus
Liver Cancer - Liver cancer cells reveal a link between angiogenesis and drug resistance
Liver Cancer - Researchers publish new studies and findings in the area of liver cancer
Mergers & Acquisitions - Dynavax to acquire Rhein Biotech GmbH from Crucell
Obesity Pathogenesis - Cirrhosis risk slightly lower from non-alcoholic steatohepatitis than from hepatitis C, study shows
SARS - Recent findings in SARS described
Stem Cell Transplantation - Cultured BMCs differentiated into liver cell lineage are cell transplantation source
T Cells - T cells activated within the transplanted liver are completely differentiated
Tissue Engineering - Cell-cell competition replaces functional organ tissue under nonselective conditions
Virology - Findings in virology provide new insights
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.